Typically, patients with MEN1 were reported to develop hyperparathyroidism; pancreatic NETs (NF-pNEN > gastrinoma > insulinoma >> other); and pituitary adenomas [50,281,290,325,326]. This evidence concerns the gene MEN1 and hyperparathyroidism.